Found: 2
Select item for more details and to access through your institution.
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease‐positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E204, doi. 10.1002/ajh.26537
- By:
- Publication type:
- Article
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 993, doi. 10.1002/ajh.22161
- By:
- Publication type:
- Article